Cohance Lifesciences Ltd.

₹441.55

- 4.10 (-0.92%)

04:01 pm - close price

BSE: COHANCE

NSE: COHANCE

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 4.68Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.68Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 6.12Good: 20

❌

Current Ratio

Bad: 1Current: 2.78Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 4.02Good: 15

❌

Debt to Total Assets

Bad: 1Current: 2.96Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 4.68Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.68Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 6.12Good: 20

❌

Current Ratio

Bad: 1Current: 2.78Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 4.02Good: 15

❌

Debt to Total Assets

Bad: 1Current: 2.96Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	231.05	219.82	252.93	230.69
Expenditure+	133.09	154.68	179.59	150.76
Other Income+	19.84	14.34	17.05	18.16
Operating Profit	97.96	65.14	73.34	79.93
Interest	0.50	1.27	2.30	1.60
Depreciation and Amortization	11.89	12.75	17.25	13.40
Profit Before Tax	105.41	65.47	70.85	83.09
Tax+	25.84	18.71	17.48	22.32
Net Profit	79.56	46.75	53.37	60.77

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	132022.21	134032.88	1051.35	2608.50	2268.55
Operational Expenses+	73850.02	76616.55	645.54	1811.44	1841.56
Operating Profit	58172.19	57416.33	405.81	797.06	426.99
Other Income	9238.03	4636.38	61.91	69.21	34.09
OPM %	44.06	42.84	38.60	30.56	18.82
Depreciation and Amortisation	3909.72	4798.64	54.60	166.80	187.33
Interest	852.75	1281.09	7.45	41.06	37.24
Profit Before Tax	66758.98	55972.98	405.67	642.63	207.04
Tax	21378.49	15061.18	106.17	154.13	52.23
Net Profit	45380.49	41129.03	300.28	487.34	179.23

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	196681.33	211006.54	2254.10	5480.41	5727.00
Liabilities+	196681.33	211006.54	2254.10	5480.41	5727.00

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	33000.02	45719.58	384.77	673.35	368.32
Cash from Investing Activity	-13613.83	-19500.56	-362.35	-389.70	-254.57
Cash from Financing Activity	-15648.07	-24195.12	-39.99	-327.40	-165.15
Net Cash Flow	3738.12	2023.90	-17.57	-43.75	-51.40
Opening Cash & Cash Equivalents	718.22	4456.38	64.80	138.32	96.65
Closing Cash & Cash Equivalents	4456.38	6480.28	47.23	96.65	49.14

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	57.49	57.49	57.49	57.49	66.41	50.10	50.10	50.10	50.10	50.10
Public+	42.51	42.51	42.51	42.51	33.59	49.90	49.90	49.90	49.90	49.90
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	99149	85230	81877	75284	80910	86325	84210	69337	65777	68932

Corporate Actions

261 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	33000.02	45719.58	384.77	673.35	368.32
Cash from Investing Activity	-13613.83	-19500.56	-362.35	-389.70	-254.57
Cash from Financing Activity	-15648.07	-24195.12	-39.99	-327.40	-165.15
Net Cash Flow	3738.12	2023.90	-17.57	-43.75	-51.40
Opening Cash & Cash Equivalents	718.22	4456.38	64.80	138.32	96.65
Closing Cash & Cash Equivalents	4456.38	6480.28	47.23	96.65	49.14

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	196681.33	211006.54	2254.10	5480.41	5727.00
Liabilities+	196681.33	211006.54	2254.10	5480.41	5727.00

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	57.49	57.49	57.49	57.49	66.41	50.10	50.10	50.10	50.10	50.10
Public+	42.51	42.51	42.51	42.51	33.59	49.90	49.90	49.90	49.90	49.90
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	99149	85230	81877	75284	80910	86325	84210	69337	65777	68932

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	231.05	219.82	252.93	230.69
Expenditure+	133.09	154.68	179.59	150.76
Other Income+	19.84	14.34	17.05	18.16
Operating Profit	97.96	65.14	73.34	79.93
Interest	0.50	1.27	2.30	1.60
Depreciation and Amortization	11.89	12.75	17.25	13.40
Profit Before Tax	105.41	65.47	70.85	83.09
Tax+	25.84	18.71	17.48	22.32
Net Profit	79.56	46.75	53.37	60.77

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	132022.21	134032.88	1051.35	2608.50	2268.55
Operational Expenses+	73850.02	76616.55	645.54	1811.44	1841.56
Operating Profit	58172.19	57416.33	405.81	797.06	426.99
Other Income	9238.03	4636.38	61.91	69.21	34.09
OPM %	44.06	42.84	38.60	30.56	18.82
Depreciation and Amortisation	3909.72	4798.64	54.60	166.80	187.33
Interest	852.75	1281.09	7.45	41.06	37.24
Profit Before Tax	66758.98	55972.98	405.67	642.63	207.04
Tax	21378.49	15061.18	106.17	154.13	52.23
Net Profit	45380.49	41129.03	300.28	487.34	179.23

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Ratios

Reported EPS

Bad: 2Current: 4.68Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.68Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 6.12Good: 20

❌

Current Ratio

Bad: 1Current: 2.78Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 4.02Good: 15

❌

Debt to Total Assets

Bad: 1Current: 2.96Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 4.68Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.68Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 6.12Good: 20

❌

Current Ratio

Bad: 1Current: 2.78Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 4.02Good: 15

❌

Debt to Total Assets

Bad: 1Current: 2.96Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cohance Lifesciences Ltd.

₹441.55

- 4.10 (-0.92%)

04:01 pm - close price

BSE: COHANCE

NSE: COHANCE

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

261 events in the last 3 years